Teva Pharmaceutical has announced the FDA approved Vantrela ER (hydrocodone bitartrate) extended-release tablets [CII] formulated with Teva’s proprietary abuse deterrence...
Zogenix, Inc. announced today that it has entered into a definitive agreement to sell its Zohydro ER (hydrocodone bitartrate) business...